Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Venous Thromboembolism”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableEnded earlyNCT00428441
What this trial is testing

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Università degli Studi dell'Insubria 73
Not applicableEnded earlyNCT05966740
What this trial is testing

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 5
Not applicableUnknownNCT00261014
What this trial is testing

Understanding Risk Factors Involved in Developing a Second Blood Clot.

Who this might be right for
Deep Vein Thrombosis
Ottawa Hospital Research Institute 800
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Not applicableStudy completedNCT02884934
What this trial is testing

Six Years of Follow-up After Idiopathic Venous Throbmoembolism

Who this might be right for
Pulmonary EmbolismProximal Deep Vein Thrombosis
University Hospital, Brest 409
Large-scale testing (Phase 3)Study completedNCT00740493
What this trial is testing

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Who this might be right for
Recurrent Venous ThromboembolismIdiopathic Deep Vein Thrombosis
University Hospital, Brest 104
Not applicableStudy completedNCT03214172
What this trial is testing

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Who this might be right for
Venous Thromboembolism
Bayer 1,000
Post-approval studies (Phase 4)Study completedNCT01828697
What this trial is testing

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

Who this might be right for
Deep Venous ThrombosisPulmonary Embolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,110
Not applicableLooking for participantsNCT06372730
What this trial is testing

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)

Who this might be right for
Pulmonary EmbolismVenous Thromboembolism
University Hospital, Brest 665
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableActive Not RecruitingNCT06087952
What this trial is testing

Leiden Thrombosis Recurrence Risk Prevention

Who this might be right for
Venous ThromboembolismVenous ThrombosesPulmonary Embolism+1 more
Leiden University Medical Center 608
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Post-approval studies (Phase 4)Study completedNCT00967304
What this trial is testing

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Who this might be right for
Idiopathic Venous Thromboembolism
Ottawa Hospital Research Institute 2,779
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Next Page